Evidence map›Paper›PMID 32722132›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Synthesis of Radioluminescent CaF

Hayden Winter, Megan J Neufeld, Lydia Makotamo, Conroy Sun, Andrea M Goforth

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hayden WinterDepartment of Chemistry, Portland State University, 1719 SW 10th Ave., Portland, OR 97201, USA.
Megan J NeufeldDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA.ORCID 0000-0003-0812-2208
Lydia MakotamoDepartment of Chemistry, Portland State University, 1719 SW 10th Ave., Portland, OR 97201, USA.
Conroy SunDepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USA.ORCID 0000-0001-5193-6907
Andrea M GoforthDepartment of Chemistry, Portland State University, 1719 SW 10th Ave., Portland, OR 97201, USA.ORCID 0000-0002-6304-2924
Portland State University · USOregon State University · US

Funding

NIH HHS 1R35GM119839-01Portland State University FEA-AMG 17-19
6 · The paper itself

Abstract

X-ray radiotherapy is a common method of treating cancerous tumors or other malignant lesions. The side effects of this treatment, however, can be deleterious to patient quality of life if critical tissues are affected. To potentially lower the effective doses of radiation and negative side-effects, new classes of nanoparticles are being developed to enhance reactive oxygen species production during irradiation. This report presents the synthesis and radiotherapeutic efficacy evaluation of a new nanoparticle formulation designed for this purpose, composed of a CaF

Indexed as

CaF2core-shellhydrothermal annealinglanthanide-dopedmesoporous silicananoparticlepolyethylene glycolradioluminescenceradiotherapy

Identifiers

PMID32722132
PMCPMC7466269
OpenAlexW3044300016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.